US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist

10.090
-0.770-7.09%

Close Feb 28 16:00 ET

10.100
+0.010+0.10%

Post 20:01 ET

1.04BMarket Cap-1.92P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.47%-348.88M

8.45%-85.2M

16.32%-84.84M

35.58%-58.19M

-10.37%-120.66M

-18.24%-394.09M

-3.54%-93.05M

-29.11%-101.38M

-6.15%-90.32M

-37.00%-109.33M

Net income from continuing operations

-7.86%-519.02M

2.47%-128.9M

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

Operating gains losses

-100.48%-76K

--0

----

43.86%15.71M

47.63%4.8M

130.08%3.85M

23.46%4.02M

11.04%3.05M

Depreciation and amortization

14.58%10.29M

4.06%2.57M

13.89%2.61M

19.77%2.6M

22.54%2.51M

18.54%8.98M

21.42%2.47M

17.44%2.29M

18.13%2.17M

16.88%2.05M

Other non cash items

-411.82%-20.97M

--0

-820.02%-20.97M

-91.69%6.72M

--0

-90.94%968K

6.44%2.84M

-95.08%2.91M

Change In working capital

122.65%11.88M

-34.41%2.04M

172.61%9.94M

695.46%29.62M

19.43%-29.73M

2.64%-52.45M

123.18%3.11M

-142.66%-13.69M

71.15%-4.98M

-110.02%-36.9M

-Change in receivables

185.47%27.94M

101.12%337K

342.26%3.47M

16,059.60%24.1M

102.55%29K

-1,781.87%-32.69M

-11,850.98%-29.97M

-22.77%-1.43M

85.67%-151K

-594.78%-1.14M

-Change in prepaid assets

119.08%5.18M

103.52%541K

289.98%10.88M

298.50%2.51M

-81.64%-8.75M

-1,157.78%-27.17M

-695.13%-15.36M

-765.26%-5.73M

-10,625.00%-1.26M

-1,241.00%-4.82M

-Change in payables and accrued expense

-141.93%-3.58M

-58.46%5.39M

-63.17%667K

-27.93%7.2M

-3.77%-16.83M

-24.64%8.55M

239.43%12.97M

-84.84%1.81M

1,619.63%9.98M

-329.84%-16.22M

-Change in other current assets

22.28%22.38M

17.45%5.86M

14.00%5.06M

25.54%5.78M

33.06%5.68M

52.15%18.3M

11.03%4.99M

49.66%4.44M

63.70%4.61M

143.30%4.27M

-Change in other current liabilities

-7.81%-17.97M

4.71%-4.25M

-16.92%-4.67M

-20.33%-4.57M

-1.43%-4.48M

-68.67%-16.67M

-33.58%-4.46M

-91.29%-4M

-68.46%-3.8M

-100.54%-4.42M

-Change in other working capital

-694.67%-22.08M

-116.73%-5.85M

37.70%-5.47M

62.45%-5.39M

63.15%-5.37M

95.62%-2.78M

308.83%34.93M

47.20%-8.79M

10.87%-14.35M

-4.08%-14.57M

Cash from discontinued investing activities

Operating cash flow

11.47%-348.88M

8.45%-85.2M

16.32%-84.84M

35.58%-58.19M

-10.37%-120.66M

-18.24%-394.09M

-3.54%-93.05M

-29.11%-101.38M

-6.15%-90.32M

-37.00%-109.33M

Investing cash flow

Cash flow from continuing investing activities

500.57%125.57M

229.93%151.57M

-109.70%-7.71M

29.96%-24.19M

104.83%5.9M

-119.55%-31.35M

252.36%45.94M

66.87%79.5M

-136.22%-34.54M

-357.51%-122.25M

Net PPE purchase and sale

58.68%-5.78M

35.46%-981K

70.48%-1.28M

76.47%-1.01M

34.60%-2.51M

-4.30%-13.99M

61.15%-1.52M

-5.99%-4.33M

-8.07%-4.3M

-168.16%-3.83M

Net intangibles purchase and sale

--0

----

--0

----

Net investment purchase and sale

856.51%131.35M

221.43%152.55M

-107.67%-6.43M

23.35%-23.18M

107.10%8.41M

-107.94%-17.36M

280.87%47.46M

62.06%83.83M

-130.44%-30.24M

-226.33%-118.42M

Cash from discontinued investing activities

Investing cash flow

500.57%125.57M

229.93%151.57M

-109.70%-7.71M

29.96%-24.19M

104.83%5.9M

-119.55%-31.35M

252.36%45.94M

66.87%79.5M

-136.22%-34.54M

-357.51%-122.25M

Financing cash flow

Cash flow from continuing financing activities

42.53%185.75M

-97.82%2.32M

330.28%82.19M

1,539.35%41.25M

2,601.13%59.99M

-77.64%130.32M

-78.95%106.48M

-20.33%19.1M

-57.32%2.52M

-95.31%2.22M

Net common stock issuance

47.67%176.9M

-100.03%-30K

446.93%80.5M

--38.4M

3,858.66%58.03M

-78.83%119.8M

-79.43%103.61M

-36.71%14.72M

--0

-96.23%1.47M

Proceeds from stock option exercised by employees

-15.96%8.85M

-18.31%2.35M

-61.34%1.7M

13.20%2.85M

159.34%1.96M

-38.67%10.53M

35.90%2.87M

507.20%4.38M

-57.32%2.52M

-91.05%755K

Cash from discontinued financing activities

Financing cash flow

42.53%185.75M

-97.82%2.32M

330.28%82.19M

1,539.35%41.25M

2,601.13%59.99M

-77.64%130.32M

-78.95%106.48M

-20.33%19.1M

-57.32%2.52M

-95.31%2.22M

Net cash flow

Beginning cash position

-55.11%240.35M

-25.91%134.1M

-21.39%144.45M

-39.37%185.58M

-55.11%240.35M

326.71%535.46M

20.88%180.98M

17.33%183.76M

117.90%306.11M

326.71%535.46M

Current changes in cash

87.27%-37.57M

15.70%68.69M

-272.58%-10.35M

66.38%-41.13M

76.12%-54.77M

-171.98%-295.11M

-84.61%59.37M

59.76%-2.78M

-857.60%-122.35M

-1,629.85%-229.36M

End cash Position

-15.63%202.79M

-25.91%134.1M

-21.39%144.45M

-39.37%185.58M

-55.11%240.35M

20.88%180.98M

17.33%183.76M

117.90%306.11M

Free cash flow

13.09%-354.66M

8.88%-86.18M

18.54%-86.12M

37.44%-59.2M

-8.84%-123.17M

-4.19%-408.07M

-0.85%-94.57M

-27.73%-105.71M

-6.23%-94.62M

10.23%-113.16M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.47%-348.88M	8.45%-85.2M	16.32%-84.84M	35.58%-58.19M	-10.37%-120.66M	-18.24%-394.09M	-3.54%-93.05M	-29.11%-101.38M	-6.15%-90.32M	-37.00%-109.33M
Net income from continuing operations	-7.86%-519.02M	2.47%-128.9M	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M
Operating gains losses	-100.48%-76K	--0	----	----	----	43.86%15.71M	47.63%4.8M	130.08%3.85M	23.46%4.02M	11.04%3.05M
Depreciation and amortization	14.58%10.29M	4.06%2.57M	13.89%2.61M	19.77%2.6M	22.54%2.51M	18.54%8.98M	21.42%2.47M	17.44%2.29M	18.13%2.17M	16.88%2.05M
Other non cash items	-411.82%-20.97M	--0	--0	--0	-820.02%-20.97M	-91.69%6.72M	--0	-90.94%968K	6.44%2.84M	-95.08%2.91M
Change In working capital	122.65%11.88M	-34.41%2.04M	172.61%9.94M	695.46%29.62M	19.43%-29.73M	2.64%-52.45M	123.18%3.11M	-142.66%-13.69M	71.15%-4.98M	-110.02%-36.9M
-Change in receivables	185.47%27.94M	101.12%337K	342.26%3.47M	16,059.60%24.1M	102.55%29K	-1,781.87%-32.69M	-11,850.98%-29.97M	-22.77%-1.43M	85.67%-151K	-594.78%-1.14M
-Change in prepaid assets	119.08%5.18M	103.52%541K	289.98%10.88M	298.50%2.51M	-81.64%-8.75M	-1,157.78%-27.17M	-695.13%-15.36M	-765.26%-5.73M	-10,625.00%-1.26M	-1,241.00%-4.82M
-Change in payables and accrued expense	-141.93%-3.58M	-58.46%5.39M	-63.17%667K	-27.93%7.2M	-3.77%-16.83M	-24.64%8.55M	239.43%12.97M	-84.84%1.81M	1,619.63%9.98M	-329.84%-16.22M
-Change in other current assets	22.28%22.38M	17.45%5.86M	14.00%5.06M	25.54%5.78M	33.06%5.68M	52.15%18.3M	11.03%4.99M	49.66%4.44M	63.70%4.61M	143.30%4.27M
-Change in other current liabilities	-7.81%-17.97M	4.71%-4.25M	-16.92%-4.67M	-20.33%-4.57M	-1.43%-4.48M	-68.67%-16.67M	-33.58%-4.46M	-91.29%-4M	-68.46%-3.8M	-100.54%-4.42M
-Change in other working capital	-694.67%-22.08M	-116.73%-5.85M	37.70%-5.47M	62.45%-5.39M	63.15%-5.37M	95.62%-2.78M	308.83%34.93M	47.20%-8.79M	10.87%-14.35M	-4.08%-14.57M
Cash from discontinued investing activities
Operating cash flow	11.47%-348.88M	8.45%-85.2M	16.32%-84.84M	35.58%-58.19M	-10.37%-120.66M	-18.24%-394.09M	-3.54%-93.05M	-29.11%-101.38M	-6.15%-90.32M	-37.00%-109.33M
Investing cash flow
Cash flow from continuing investing activities	500.57%125.57M	229.93%151.57M	-109.70%-7.71M	29.96%-24.19M	104.83%5.9M	-119.55%-31.35M	252.36%45.94M	66.87%79.5M	-136.22%-34.54M	-357.51%-122.25M
Net PPE purchase and sale	58.68%-5.78M	35.46%-981K	70.48%-1.28M	76.47%-1.01M	34.60%-2.51M	-4.30%-13.99M	61.15%-1.52M	-5.99%-4.33M	-8.07%-4.3M	-168.16%-3.83M
Net intangibles purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	856.51%131.35M	221.43%152.55M	-107.67%-6.43M	23.35%-23.18M	107.10%8.41M	-107.94%-17.36M	280.87%47.46M	62.06%83.83M	-130.44%-30.24M	-226.33%-118.42M
Cash from discontinued investing activities
Investing cash flow	500.57%125.57M	229.93%151.57M	-109.70%-7.71M	29.96%-24.19M	104.83%5.9M	-119.55%-31.35M	252.36%45.94M	66.87%79.5M	-136.22%-34.54M	-357.51%-122.25M
Financing cash flow
Cash flow from continuing financing activities	42.53%185.75M	-97.82%2.32M	330.28%82.19M	1,539.35%41.25M	2,601.13%59.99M	-77.64%130.32M	-78.95%106.48M	-20.33%19.1M	-57.32%2.52M	-95.31%2.22M
Net common stock issuance	47.67%176.9M	-100.03%-30K	446.93%80.5M	--38.4M	3,858.66%58.03M	-78.83%119.8M	-79.43%103.61M	-36.71%14.72M	--0	-96.23%1.47M
Proceeds from stock option exercised by employees	-15.96%8.85M	-18.31%2.35M	-61.34%1.7M	13.20%2.85M	159.34%1.96M	-38.67%10.53M	35.90%2.87M	507.20%4.38M	-57.32%2.52M	-91.05%755K
Cash from discontinued financing activities
Financing cash flow	42.53%185.75M	-97.82%2.32M	330.28%82.19M	1,539.35%41.25M	2,601.13%59.99M	-77.64%130.32M	-78.95%106.48M	-20.33%19.1M	-57.32%2.52M	-95.31%2.22M
Net cash flow
Beginning cash position	-55.11%240.35M	-25.91%134.1M	-21.39%144.45M	-39.37%185.58M	-55.11%240.35M	326.71%535.46M	20.88%180.98M	17.33%183.76M	117.90%306.11M	326.71%535.46M
Current changes in cash	87.27%-37.57M	15.70%68.69M	-272.58%-10.35M	66.38%-41.13M	76.12%-54.77M	-171.98%-295.11M	-84.61%59.37M	59.76%-2.78M	-857.60%-122.35M	-1,629.85%-229.36M
End cash Position	-15.63%202.79M	-15.63%202.79M	-25.91%134.1M	-21.39%144.45M	-39.37%185.58M	-55.11%240.35M	-55.11%240.35M	20.88%180.98M	17.33%183.76M	117.90%306.11M
Free cash flow	13.09%-354.66M	8.88%-86.18M	18.54%-86.12M	37.44%-59.2M	-8.84%-123.17M	-4.19%-408.07M	-0.85%-94.57M	-27.73%-105.71M	-6.23%-94.62M	10.23%-113.16M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--